Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Profound Medical | PROF | Jan 17, 2025 | 7.35 | -1.08 |
ProFrac A | ACDC | Jan 17, 2025 | 8.91 | -3.36 |
PROG | PRG | Jan 17, 2025 | 43.11 | +0.49 |
Progress Software | PRGS | Jan 17, 2025 | 62.94 | -1.22 |
Progressive | PGR | Jan 17, 2025 | 243.68 | -0.76 |
Progyny | PGNY | Jan 17, 2025 | 21.00 | +1.84 |
ProKidney | PROK | Jan 17, 2025 | 1.66 | +0.61 |
Prologis | PLD | Jan 17, 2025 | 109.48 | -1.31 |
ProMIS Neurosciences | PMN | Jan 17, 2025 | 0.89 | -2.19 |
PropertyGuru | PGRU | Jan 17, 2025 | 6.70 | 0.00 |
ProPetro | PUMP | Jan 17, 2025 | 10.90 | -0.46 |
ProPhase Labs | PRPH | Jan 17, 2025 | 0.60 | -0.78 |
ProQR Therapeutics | PRQR | Jan 17, 2025 | 2.37 | +3.04 |
PROS | PRO | Jan 17, 2025 | 22.35 | +2.90 |
ProShares Bitcoin Strategy ETF | BITO | Jan 17, 2025 | 25.49 | +4.42 |
Proshares Ultra FTSE Europe | UPV | Jan 17, 2025 | 57.13 | +0.86 |
ProShares UltraShort Bloomberg Natural Gas | KOLD | Jan 17, 2025 | 32.30 | +14.86 |
Proshares Ultrashort FTSE Europe | EPV | Jan 17, 2025 | 39.62 | -0.89 |
Prospect Capital | PSEC | Jan 17, 2025 | 4.33 | +0.23 |
Prospect Capital A Pref | PSEC-A | Jan 17, 2025 | 16.72 | -1.18 |
Prosperity Bancshares | PB | Jan 17, 2025 | 78.87 | +1.15 |
Protagenic Therapeutics | PTIX | Jan 17, 2025 | 0.44 | -2.01 |
Protagonist Therapeutics | PTGX | Jan 17, 2025 | 36.82 | +0.77 |
Protalix Bio Therapeutics | PLX | Jan 17, 2025 | 2.22 | +2.30 |
Protara Therapeutics | TARA | Jan 17, 2025 | 4.55 | -1.73 |
Prothena | PRTA | Jan 17, 2025 | 13.77 | +4.48 |
Proto Labs | PRLB | Jan 17, 2025 | 38.54 | -1.05 |
Provident Bancorp | PVBC | Jan 17, 2025 | 10.87 | +1.21 |
Provident Financial | PROV | Jan 17, 2025 | 14.87 | +1.16 |
Provident Financial Services | PFS | Jan 17, 2025 | 19.32 | +0.42 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.